Kerecis Graftguide
Payments companies reported to CMS as associated with Kerecis Graftguide. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Kerecis Graftguide, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Kerecis Graftguide
These are the largest totals companies reported as associated with Kerecis Graftguide. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Lantis | New York, NY | Vascular Surgery | $155,267.36 |
| Rajiv Sood | Augusta, GA | Plastic and Reconstructive Surgery | $112,520.19 |
| Alfredo Cordova | Sarasota, FL | Surgical Critical Care | $101,304.29 |
| Atif Baqai | Park Ridge, IL | Vascular Surgery | $98,897.32 |
| Mark Suski | Thousand Oaks, CA | Plastic and Reconstructive Surgery | $83,253.83 |
| Michael Lacqua | Brooklyn, NY | Plastic Surgery | $57,076.45 |
| James Melville | Houston, TX | Oral and Maxillofacial Surgery | $53,930.30 |
| Jenna Wishnew | Frisco, TX | Surgery | $53,285.81 |
| Jonathan Richards | Englewood, NJ | Podiatrist | $52,891.63 |
| James Cottom | Sarasota, FL | Podiatrist | $51,744.49 |
Prescribed Kerecis Graftguide?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.